Biophama companies are increasingly interested in establishing relationships with experienced specialty pharmacies to dispense rare disease drugs to patients
Alnylam® Pharmaceuticals selected PantherRx Rare and Orsini Specialty Pharmacy as limited distribution partners for OXLUMO™ (lumasiran). OXLUMO is the first and only treatment approved for primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients. PH1 is an ultra-rare genetic disease characterized by the overproduction of oxalate, a waste product that […]
OutcomeRx focuses on engaging with biotech companies to think through, structure, and manage value-based agreements
The number of chronic infusion therapies for neuromuscular disorders continues to grow
Both Gavreto and AYVAKIT are available through Blueprint’s specialty distribution network and two specialty pharmacies: Biologics by McKesson and PantherRx
RareMed Solutions is the nation’s only (pure) rare and devastating disorder patient service provider (PSP)
The pharmacies will offer 24/7 access to clinical support staff as well as disease prevention, treatment education and free prescription drug delivery as well as hard-to-find specialty drugs.
US Oncology helps independent physicians deliver value-based, integrated care to patients